These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 33606112)
21. Impairing the function of MLCK, myosin Va or myosin Vb disrupts Rhinovirus B14 replication. Real-Hohn A; Provance DW; Gonçalves RB; Denani CB; de Oliveira AC; Salerno VP; Oliveira Gomes AM Sci Rep; 2017 Dec; 7(1):17153. PubMed ID: 29215055 [TBL] [Abstract][Full Text] [Related]
22. DNA-AuNP networks on cell membranes as a protective barrier to inhibit viral attachment, entry and budding. Li CM; Zheng LL; Yang XX; Wan XY; Wu WB; Zhen SJ; Li YF; Luo LF; Huang CZ Biomaterials; 2016 Jan; 77():216-26. PubMed ID: 26606447 [TBL] [Abstract][Full Text] [Related]
23. Antiviral effect of bovine lactoferrin saturated with metal ions on early steps of human immunodeficiency virus type 1 infection. Puddu P; Borghi P; Gessani S; Valenti P; Belardelli F; Seganti L Int J Biochem Cell Biol; 1998 Sep; 30(9):1055-62. PubMed ID: 9785469 [TBL] [Abstract][Full Text] [Related]
24. Epigallocatechin-3-gallate inhibits the early stages of Japanese encephalitis virus infection. Wang CY; Hour MJ; Lai HC; Chen CH; Chang PJ; Huang SH; Lin CW Virus Res; 2018 Jul; 253():140-146. PubMed ID: 29958923 [TBL] [Abstract][Full Text] [Related]
25. Lactoferrin inhibits human papillomavirus binding and uptake in vitro. Drobni P; Näslund J; Evander M Antiviral Res; 2004 Oct; 64(1):63-8. PubMed ID: 15451180 [TBL] [Abstract][Full Text] [Related]
26. Bovine lactoferrin-derived peptides as novel broad-spectrum inhibitors of influenza virus. Ammendolia MG; Agamennone M; Pietrantoni A; Lannutti F; Siciliano RA; De Giulio B; Amici C; Superti F Pathog Glob Health; 2012 Mar; 106(1):12-9. PubMed ID: 22595270 [TBL] [Abstract][Full Text] [Related]
28. Enhanced human enterovirus 71 infection by endocytosis inhibitors reveals multiple entry pathways by enterovirus causing hand-foot-and-mouth diseases. Yuan M; Yan J; Xun J; Chen C; Zhang Y; Wang M; Chu W; Song Z; Hu Y; Zhang S; Zhang X Virol J; 2018 Jan; 15(1):1. PubMed ID: 29298696 [TBL] [Abstract][Full Text] [Related]
29. Strategies for antiviral screening targeting early steps of virus infection. Peng T Virol Sin; 2010 Aug; 25(4):281-93. PubMed ID: 20960301 [TBL] [Abstract][Full Text] [Related]
30. Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes. Ikeda M; Sugiyama K; Tanaka T; Tanaka K; Sekihara H; Shimotohno K; Kato N Biochem Biophys Res Commun; 1998 Apr; 245(2):549-53. PubMed ID: 9571193 [TBL] [Abstract][Full Text] [Related]
31. Lack of effect of bovine lactoferrin in respiratory syncytial virus replication and clinical disease severity in the mouse model. Gualdi L; Mertz S; Gomez AM; Ramilo O; Wittke A; Mejias A Antiviral Res; 2013 Aug; 99(2):188-95. PubMed ID: 23735300 [TBL] [Abstract][Full Text] [Related]
32. Bovine lactoferrin increases the poly(I:C)-induced antiviral response in vitro. Kobayashi-Sakamoto M; Maeda T; Kimura M; Yusa J; Ito H; Tani H; Kato Y; Hirose K Biochem Cell Biol; 2022 Aug; 100(4):338-348. PubMed ID: 35830725 [TBL] [Abstract][Full Text] [Related]
33. Ficus religiosa L. bark extracts inhibit human rhinovirus and respiratory syncytial virus infection in vitro. Cagno V; Civra A; Kumar R; Pradhan S; Donalisio M; Sinha BN; Ghosh M; Lembo D J Ethnopharmacol; 2015 Dec; 176():252-7. PubMed ID: 26528588 [TBL] [Abstract][Full Text] [Related]
34. Effectiveness of human, camel, bovine and sheep lactoferrin on the hepatitis C virus cellular infectivity: comparison study. El-Fakharany EM; Sánchez L; Al-Mehdar HA; Redwan EM Virol J; 2013 Jun; 10():199. PubMed ID: 23782993 [TBL] [Abstract][Full Text] [Related]
35. Lactoferrin inhibits early steps of human BK polyomavirus infection. Longhi G; Pietropaolo V; Mischitelli M; Longhi C; Conte MP; Marchetti M; Tinari A; Valenti P; Degener AM; Seganti L; Superti F Antiviral Res; 2006 Nov; 72(2):145-52. PubMed ID: 16774792 [TBL] [Abstract][Full Text] [Related]
36. Role of sialylated glycans on bovine lactoferrin against influenza virus. Wang X; Yue L; Dang L; Yang J; Chen Z; Wang X; Shu J; Li Z Glycoconj J; 2021 Dec; 38(6):689-696. PubMed ID: 34779975 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of HBV infection by bovine lactoferrin and iron-, zinc-saturated lactoferrin. Li S; Zhou H; Huang G; Liu N Med Microbiol Immunol; 2009 Feb; 198(1):19-25. PubMed ID: 18810491 [TBL] [Abstract][Full Text] [Related]
38. In Vitro Exploration of the Anti-HCV Potential of the Synthetic Spacer Peptides Derived from Human, Bovine, and Camel Lactoferrins. Albar AH; El-Fakharany EM; Almehdar HA; Uversky VN; Redwan EM Protein Pept Lett; 2017; 24(10):909-921. PubMed ID: 27834141 [TBL] [Abstract][Full Text] [Related]
40. [Study of inhibition effect of zinc-, iron- and manganese-saturated bovine lactoferrin on hepatitis B virus DNA in vitro]. Zhou H; Li S; Huang G; Liu N Wei Sheng Yan Jiu; 2008 Sep; 37(5):586-9. PubMed ID: 19069661 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]